SPINAL MUSCULAR ATROPHY TYPE 3
Clinical trials for SPINAL MUSCULAR ATROPHY TYPE 3 explained in plain language.
Never miss a new study
Get alerted when new SPINAL MUSCULAR ATROPHY TYPE 3 trials appear
Sign up with your email to follow new studies for SPINAL MUSCULAR ATROPHY TYPE 3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for kids with spinal muscular atrophy
Disease control CompletedThis study tested a new medicine called apitegromab in 188 children (ages 2–21) with later-onset spinal muscular atrophy (SMA types 2 and 3) who were already taking standard treatments. The goal was to see if adding apitegromab could further improve muscle function and movement. …
Matched conditions: SPINAL MUSCULAR ATROPHY TYPE 3
Phase: PHASE3 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated May 26, 2026 08:54 UTC
-
Spinal zap trial aims to help SMA patients move better
Knowledge-focused CompletedThis small pilot study tested whether spinal cord stimulation (using electrodes placed near the lower back) could improve leg strength and movement in people with spinal muscular atrophy types 3 and 4. Three participants aged 16 or older who could stand independently took part. T…
Matched conditions: SPINAL MUSCULAR ATROPHY TYPE 3
Phase: NA • Sponsor: Marco Capogrosso • Aim: Knowledge-focused
Last updated May 26, 2026 08:28 UTC